Citations

Clear

815 citation(s) found for "Tang, Yu".

Role of Genotypic Analysis of the Thymidine Kinase Gene of Herpes Simplex Virus for Determination of Neurovirulence and Resistance to Acyclovir
Lee, N. Y., Espy, Mark J., Kolbert, Christopher P., Rys, Paul N., Mitchell, P. Shawn, Day, S. P., Henry, S. L., Persing, D. H., Smith, T. F., Tang, Yi‐Wei , Henry, Semakula, Smith, T. F.

Mayo Clinic

Journal of Clinical Microbiology | May 29, 2021 | Volume: 38 | Issue: 3 | Pages: 1311-1311

10.1128/jcm.38.3.1311a-1311a.2000 Get It

Abstract 13777: Coexisting Metabolic Syndrome Inhibits Myocardial Mitophagy in Renovascular Hypertensive Pigs, Aggravating Cardiac Injury and Dysfunction
Nargesi, Arash Aghajani , Farah, Mohamed C, Zhu, Xiangyang , Jordan, Kyra L., Saadiq, Ishran M. , Lerman, Lilach O. , Zhang, Lei , Tang, Hui Jun , Lerman, Amir , Eirin, Alfonso

Mayo Clinic

Circulation | May 10, 2021 | Volume: 142 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.142.suppl_3.13777 Get It

Introduction: Subjects with renovascular hypertension (RVH) often manifest with metabolic syndrome (MetS), increasing risk for heart failure, yet the mechanisms underlying cardiac injury remain unknown. Reduced mitophagy and accumulation of impaired mitochondria have been linked to progression of heart failure. Hypothesis: We hypothesized that superimposition of MetS on RVH in swine inhibits myocardial mitophagy, aggravating mitochondrial damage, cardiac injury and dysfunction. Methods: Pigs were studied after 16 weeks of RVH (renal artery stenosis) with or without diet-induced MetS, and Lean controls (n=6 each). Cardiac function was assessed in vivo (multidetector-CT), and cardiac mitochondrial structure, function, mitophagy, and myocardial fibrosis ex vivo. Results: MetS groups developed obesity, whereas RVH groups developed hypertension (Table). Mitochondrial matrix density and ATP production were lower and H2O2 production higher in both RVH groups vs. Lean and MetS (Fig. AB). However, MetS+RVH failed to activate mitophagy and downregulate myocardial expression of mitophagy-related microRNAs achieved by Lean+RVH (Fig. CD). Myocardial expression of the mitophagy marker PTEN-induced kinase (PINK)-1 inversely correlated with myocardial fibrosis (R 2 =0.195, p=0.031). Cardiac fibrosis, hypertrophy, and diastolic dysfunction (decreased E/A ratio) were greater in MetS+RVH vs. Lean+RVH (Table, Fig. E). Conclusions: MetS aggravates myocardial mitochondrial damage and dysfunction in swine RVH. MetS+RVH failed to activate mitophagy, resulting in greater cardiac remodeling, fibrosis, and diastolic dysfunction. Mitochondrial injury and impaired mitophagy may constitute important mechanisms and potential therapeutic targets to ameliorate cardiac structural damage and dysfunction in patients with coexisting MetS and RVH.
Abstract 12569: Analysis of Deep Learning Models for Prediction of Heart Failure Mortality
Krittanawong, Chayakrit , Baber, Usman , Aydar, Mehmet , Wang, Zhen , Halperin, Jonathan L. , Johnson, Kipp W. , Stewart, Matthew P. , Tang, W.H. Wilson

Mayo Clinic

Circulation | May 10, 2021 | Volume: 142 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.142.suppl_3.12569 Get It

Introduction: Heart failure (HF) is a leading cause of hospitalization, morbidity and mortality. Deep learning (DL) techniques appear to show promising results in risk stratification and prognosis in several conditions in medicine. However, few methods using DL exist to help quantitatively estimate prognosis of HF. We hypothesized that deep learning (DL) techniques could prognosis of HF using simple variables. We propose application of a custom-built deep-neural-network model to identify mortality in HF patients. Methods: Custom-built deep-neural-networks were assessed using survey data from 42,147 participants from the National Health and Nutrition Examination Survey 1999-2016 (NHANES). Variables were selected using clinical judgment and stepwise backward regressions to develop prediction models. We partitioned the data into training and testing sets and repetitive experiments. We then evaluated model performance based on discrimination and calibration including the area under the receiver-operator characteristics curve (C-statistics), balanced accuracy, probability calibration with sigmoid, and the Brier score, respectively. As sensitivity analyses, we examined results limited to cases with complete clinical information available. We validated models’ performance using Mount Sinai database. Results: Of 42,147 participants with 4,060 variables, 1,491 (3.5%) had HF and HF mortality was 51.8%. In validation cohort, of 26,333 HF patients, the mortality in HF patients was 405 (1.5%). Final model using only 20 variables (age, race, gender, BMI, smoking, alcohol consumption, HTN, COPD, SBP, DBP, HR, HDL, LDL, CRP, A1C, BUN, creatinine, hemoglobin, sodium level, on statin) was tested. A state-of-the-art deep learning models achieved high accuracy for predicting mortality in HF patients with an AUC of 0.96 (95% CI: 0.95-0.99) in the first cohort and AUC of 0.93 (95% CI: 0.91-0.96) in validation cohort. Conclusions: A deep neural network model has shown to have high predictive accuracy and discriminative and calibrative power for prediction of HF mortality. Further research can delineate the clinical implications of DL in predicting HF mortality.
Evaluation of SrAl2O4:Eu, Dy phosphor for potential applications in thermoluminescent dosimetry
Tang, Xueyan , Ehler, E , Brost, Eric, Mathew, Damien , Tang, Xueyan

Mayo Clinic

Journal of Applied Clinical Medical Physics | May 6, 2021 | Volume: 22 | Issue: 5 | Pages: 191-197

10.1002/acm2.13251 | PMID 33951293 Get It

AbstractPurposeTo evaluate the use of commercial‐grade strontium aluminate phosphorescent powder as a thermoluminescent (TL) dosimeter for clinical radiotherapy beams.Materials and MethodCommercially available Eu2+, Dy3+ co‐doped strontium aluminate powder (SrAl2O4:Eu, Dy) was annealed and then irradiated using 20 × 20 cm2 field size, with 6‐MV (PDD10 = 70.7) and 18‐MV (PDD10 = 79.4) photon beams and and 9‐MeV (R50 = 3.6), 15 MeV (R50 = 5.9) and 18‐MeV (R50 = 7.2) electron beams. To calibrate the relationship between the TL readings and the irradiated doses, TL glow curves were acquired for doses up to 600 cGy at all beam energies. For the percentage depth dose (PDD) measurement, the SrAl2O4:Eu, Dy powder was sandwiched by solid water phantoms, with varying thickness of solid water placed above to determine the depth. PDDs were measured at four representative depths and compared against the commissioning depth dose data for each beam energy.ResultsLinear dose response models of doses up to 200 cGy were created for all beam energies. Superlinearity was observed with doses greater than 200 cGy. The PDD measurement acquired experimentally agrees well with the commissioning data of the medical linear accelerator. Trapping parameters such as order of kinetics, activation energy and frequency factor have been obtained via TL glow curve analysis.ConclusionThe linear dose response demonstrates that SrAl2O4:Eu, Dy is a potential TLD dosimeter for both electron beams and photon beams at different beam energies. The PDD measurements further support its potential use in quality assurance and radiation dosimetry.
Genetic architecture of smoking: Evaluating rare variant contribution from deep whole-genome sequencing of up to 26,000 individuals
Jang, Seon-Kyeong , Arnett, Donna K. , Becker, Diane M. , Bis, Joshua C. , Bleecker, Eugene R., Fingerlin, Tasha E. , Haessler, Jeffrey, Heckbert, Susan R. , Hokanson, John E. , Judy, Renae , Justice, Anne E. , Kaplan, Robert C. , Kim, Wonji , Gladwin, Mark T. , Melander, Olle , Meyers, Deborah A. , Peljto, Anna L. , Qiao, Dandi , Reed, Robert M. , Reiner, Alex P. , Silverman, Edwin K. , Smith, Nicholas L. , Smith, Gustav, Smith, Albert V. , Tang, Weihong, Gordeuk, Victor R. , Yanek, Lisa R. , Yang, Ivana V. , Young, Kendra A. , Vrieze, Scott , Martin, Lisa , Smith, Albert V , Arnett, Donna K , Evans, Luke M. , Fialkowski, Allison , Blangero, John , Brody, Jennifer A. , Cupples, L. Adrienne , Damrauer, Scott M , David, Sean P. , Andrade, Mariza de , Gharib, Sina A. , Glahn, David C , Hwang, Shih‐Jen , Hyman, Matthew Craig , Kooperberg, Charles , Levy, Dan , Loos, Ruth J. F. , Manichaikul, Ani , Martin, Lisa W. , Nouraie, Mehdi , North, Kari E. , Oelsner, Elizabeth C. , Preuss, Michael , Psaty, Bruce M. , Rader, Daniel J , Rich, Stephen S. , Rotter, Jerome I. , Schwartz, David A. , Shadyab, Aladdin H , Taylor, Kent D. , Vasan, Ramachandran S. , Wang, Zhe , Wiggins, Kerri L. , Young, Kristin L. , Zhang, Yingze , Liu, Dajiang J. , Keller, Matthew C.

Mayo Clinic

No container title available | May 6, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-475149/v1 Get It

Abstract Background Across complex traits, common variants explain only a modest amount of variance, with SNP-heritability consistently below heritability estimates from close relatives. Here, we examined the contribution of rare variant to tobacco use risk in up to 26,000 individuals of European ancestry in the Trans-Omics for Precision Medicine (TOPMed) program with whole genome sequence (WGS;~30X coverage).Method We grouped about 35 million genetic variants by their minor allele frequencies (MAF) and linkage disequilibrium (LD) and estimated SNP-heritability for age of smoking initiation (N = 14,747), cigarettes smoked per day (N = 15,425), smoking cessation (N = 17,871) and initiation (N = 26,340) using linear mixed model. Rare variant population structure is detected and adjusted for by permutation procedure. We estimated an upper bound for narrow-sense heritability for tobacco use using available pedigrees consisting of close relatives in TOPMed.Results Rare variants with MAF 0.1–0.01%, mostly from non-protein altering region, accounted for 26% of variation in age of initiation and 15% for cessation. Follow-up analysis indicated that about one-third of these rare variants contribtion is potentially confounded with rare variants structure even after adjusting for principal components. After further conservative adjustment of population structure, we estimated SNP-based heritability to be 0.21 (SE = 0.08) for age of initiation, 0.15 (0.06) for cigarettes per day, 0.21 (0.09) for cessation, and 0.24 (0.07) for initiation, 1.8–4.5 times higher than previous SNP-based estimates. Our pedigree-based upper-bound for SNP-based heritability ranged from 0.18–0.35.Conclusion The substantial contribution of rare variants for several smoking phenotypes sheds light on the missing heritability and genetic etiology of tobacco use. It also informs fine-mapping strategies since the majority of the rare variant contribution was located in non-coding regulatory regions.
A Novel Approach to Improve Newborn Screening for Congenital Hypothyroidism by Integrating Covariate-Adjusted Results of Different Tests into CLIR Customized Interpretive Tools
Rowe, Alexander D. , Stoway, Stephanie D., Åhlman, Henrik, Arora, Vaneet, Caggana, Michele, Fornari, Anna, Hagar, Arthur F. , Marquardt, Gregg, Miller, Bobby J., Nixon, Christopher, Norgan, Andrew P. , Orsini, Joseph J. , Pettersen, Rolf D. , Piazza, Amy L. , Schubauer, Neil R., Smith, Amy C., Tang, Hao , Wei, Sainan , Zetterström, Rolf , Currier, Robert J. , Mørkrid, Lars , Rinaldo, Piero, Hagar, Arthur , Marquardt, Gregg C, Zetterström, Rolf H , Currier, Robert , Norgan, Andrew P , Hall, Patricia , Tavakoli, Norma P.

Mayo Clinic

International Journal of Neonatal Screening | April 25, 2021 | Volume: 7 | Issue: 2 | Pages: 23

10.3390/ijns7020023 | PMID 33922835 Get It

Newborn screening for congenital hypothyroidism remains challenging decades after broad implementation worldwide. Testing protocols are not uniform in terms of targets (TSH and/or T4) and protocols (parallel vs. sequential testing; one or two specimen collection times), and specificity (with or without collection of a second specimen) is overall poor. The purpose of this retrospective study is to investigate the potential impact of multivariate pattern recognition software (CLIR) to improve the post-analytical interpretation of screening results. Seven programs contributed reference data (N = 1,970,536) and two sets of true (TP, N = 1369 combined) and false (FP, N = 15,201) positive cases for validation and verification purposes, respectively. Data were adjusted for age at collection, birth weight, and location using polynomial regression models of the fifth degree to create three-dimensional regression surfaces. Customized Single Condition Tools and Dual Scatter Plots were created using CLIR to optimize the differential diagnosis between TP and FP cases in the validation set. Verification testing correctly identified 446/454 (98%) of the TP cases, and could have prevented 1931/5447 (35%) of the FP cases, with variable impact among locations (range 4% to 50%). CLIR tools either as made here or preferably standardized to the recommended uniform screening panel could improve performance of newborn screening for congenital hypothyroidism.
Mild increases in erythrocyte measures found in association with obstructive sleep apnea
Li, Taomei , Tang, Xiangdong , Covassin, Naima , Tang, Xiangdong

Mayo Clinic

Journal of Clinical Sleep Medicine | April 23, 2021 | Volume: 17 | Issue: 7 | Pages: 1515-1516

10.5664/jcsm.9330 | PMID 34212854 Get It

Mortality in acute pancreatitis with persistent organ failure is determined by the number, type, and sequence of organ systems affected
Machicado, Jorge D. , Gougol, Amir , Tan, Xiaoqing , Gao, Xiaotian , Pothoulakis, Ioannis , Talukdar, Rupjyoti , Gulla, Aistė , Stevens, Tyler , Barbu, Sorin T. , Nawaz, Haq , Gutierrez, Silvia C., Zarnescu, Narcis , Capurso, Gabriele , Easler, Jeffrey J. , Τriantafyllou, Κonstantinos , Thakkar, Shyam , Ocampo, Carlos , de‐Madaria, Enrique , Coté, Gregory A. , Conwell, Darwin L. , Hart, Phil A. , Tang, Gong , Pothoulakis, Ioannis , de-Madaria, Enrique , Paragomi, Pedram , Kochhar, Rakesh K. , Goenka, Mahesh Kumar , González, José Alberto , Singh, Vikesh K. , Ferreira, Miguel Godinho , Peláez‐Luna, Mario , Wu, Bechien U. , Papachristou, Georgios I.

Mayo Clinic

United European Gastroenterology Journal | April 19, 2021 | Volume: 9 | Issue: 2 | Pages: 139-149

10.1002/ueg2.12057 | PMID 33871926 Get It

Abstract Background Persistent organ failure (POF) is the strongest determinant of mortality in acute pancreatitis (AP). There is a paucity of data regarding the impact of different POF attributes on mortality and the role of different characteristics of systemic inflammatory response syndrome (SIRS) in the risk of developing POF. Objective We aimed to assess the association of POF dynamic features with mortality and SIRS characteristics with POF. Methods We studied 1544 AP subjects prospectively enrolled at 22 international centers (APPRENTICE consortium). First, we estimated the association of onset, duration, and maximal score of SIRS with POF. Then, we evaluated the risk of mortality based on POF onset, duration, number, type, and sequence of organs affected. Analyses were adjusted for potential confounders. Results 58% had SIRS, 11% developed POF, and 2.5% died. Early SIRS, persistent SIRS, and maximal SIRS score ≥ 3 were independently associated with higher risk of POF ( p < 0.05). Mortality risk in POF was higher with two (33%, odds ratio [OR] = 10.8, 3.3–34.9) and three (48%, OR = 20.2, 5.9–68.6) organs failing, in comparison to single POF (4%). In subjects with multiple POF, mortality was higher when the cardiovascular and respiratory systems failed first or concurrently as compared to when the renal system failed first or concurrently with other organ ( p < 0.05). In multivariate regression model, the number and sequence of organs affected in POF were associated with mortality ( p < 0.05). Onset and duration of POF had no impact mortality. Conclusion In AP patients with POF, the risk of mortality is influenced by the number, type, and sequence of organs affected. These results are useful for future revisions of AP severity classification systems.
Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal Repair
Hickson, LaTonya J. , Eirin, Alfonso , Conley, Sabena M., Taner, Timucin, Bian, Xiaohui , Saad, Ahmed , Mehta, Ramila A. , McKenzie, Travis J. , Kellogg, Todd A., Kirkland, James L. , Saadiq, Ishran M. , Jordan, Kyra L., Zhu, Xiangyang , Griffin, Matthew D. , Wijnen, André J. van , Textor, Stephen C., Lerman, Lilach O. , van Wijnen, Andre J , Griffin, Matthew D , Hickson, LaTonya J , Eirin, Alfonso , Herrmann, Sandra M. , Tchkonia, Tamar , Tang, Hui Jun , Rule, Andrew D.

Mayo Clinic

Diabetes | April 15, 2021 | Volume: 70 | Issue: 7 | Pages: 1561-1574

10.2337/db19-1268 | PMID 33858824 Get It

Mesenchymal stem/stromal cells (MSCs) facilitate repair in experimental diabetic kidney disease (DKD). However, the hyperglycemic and uremic milieu may diminish regenerative capacity of patient-derived therapy. We hypothesized that DKD reduces human MSC paracrine function. Adipose-derived MSC from 38 participants with DKD and 16 control subjects were assessed for cell surface markers, trilineage differentiation, RNA sequencing (RNA-seq), in vitro function (coculture or conditioned medium experiments with T cells and human kidney cells [HK-2]), secretome profile, and cellular senescence abundance. The direction of association between MSC function and patient characteristics were also tested. RNA-seq analysis identified 353 differentially expressed genes and downregulation of several immunomodulatory genes/pathways in DKD-MSC versus Control-MSC. DKD-MSC phenotype, differentiation, and tube formation capacity were preserved, but migration was reduced. DKD-MSC with and without interferon-γ priming inhibited T-cell proliferation greater than Control-MSC. DKD-MSC medium contained higher levels of anti-inflammatory cytokines (indoleamine 2,3-deoxygenase 1 and prostaglandin-E2) and prorepair factors (hepatocyte growth factor and stromal cell–derived factor 1) but lower IL-6 versus control-MSC medium. DKD-MSC medium protected high glucose plus transforming growth factor-β–exposed HK-2 cells by reducing apoptotic, fibrotic, and inflammatory marker expression. Few DKD-MSC functions were affected by patient characteristics, including age, sex, BMI, hemoglobin A1c, kidney function, and urine albumin excretion. However, senescence-associated β-galactosidase activity was lower in DKD-MSC from participants on metformin therapy. Therefore, while DKD altered the transcriptome and migratory function of culture-expanded MSCs, DKD-MSC functionality, trophic factor secretion, and immunomodulatory activities contributing to repair remained intact. These observations support testing of patient-derived MSC therapy and may inform preconditioning regimens in DKD clinical trials.